| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Action-Outcome Expectancies Require Orbitofrontal Neurotrophin Systems in Naïve and Cocaine-Exposed Mice
|
Pitts, Elizabeth G.
|
|
|
17 |
1 |
p. 165-177
|
artikel
|
| 2 |
Action-Outcome Expectancies Require Orbitofrontal Neurotrophin Systems in Naïve and Cocaine-Exposed Mice
|
Pitts, Elizabeth G.
|
|
|
17 |
1 |
p. 165-177
|
artikel
|
| 3 |
Action-Outcome Expectancies Require Orbitofrontal Neurotrophin Systems in Naïve and Cocaine-Exposed Mice
|
Pitts, Elizabeth G.
|
|
|
17 |
1 |
p. 165-177
|
artikel
|
| 4 |
Activation of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of Neuroinflammation through AMPK/TBK1/NF-κB Pathway in Rats
|
Xu, Weilin
|
|
|
17 |
1 |
p. 294-308
|
artikel
|
| 5 |
Activation of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of Neuroinflammation through AMPK/TBK1/NF-κB Pathway in Rats
|
Xu, Weilin
|
|
|
17 |
1 |
p. 294-308
|
artikel
|
| 6 |
Activation of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of Neuroinflammation through AMPK/TBK1/NF-κB Pathway in Rats
|
Xu, Weilin
|
|
|
17 |
1 |
p. 294-308
|
artikel
|
| 7 |
Alcohol Use Disorder Interventions Targeting Brain Sites for Both Conditioned Reward and Delayed Gratification
|
Oberlin, Brandon G.
|
|
|
17 |
1 |
p. 70-86
|
artikel
|
| 8 |
Alcohol Use Disorder Interventions Targeting Brain Sites for Both Conditioned Reward and Delayed Gratification
|
Oberlin, Brandon G.
|
|
|
17 |
1 |
p. 70-86
|
artikel
|
| 9 |
Alcohol Use Disorder Interventions Targeting Brain Sites for Both Conditioned Reward and Delayed Gratification
|
Oberlin, Brandon G.
|
|
|
17 |
1 |
p. 70-86
|
artikel
|
| 10 |
Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer’s Mouse Model
|
Wang, Tian
|
|
|
17 |
1 |
p. 178-188
|
artikel
|
| 11 |
Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer’s Mouse Model
|
Wang, Tian
|
|
|
17 |
1 |
p. 178-188
|
artikel
|
| 12 |
Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer's Mouse Model
|
Wang, Tian
|
|
|
17 |
1 |
p. 178-188
|
artikel
|
| 13 |
Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice
|
Dimitriadou, Maria M.
|
|
|
17 |
1 |
p. 235-242
|
artikel
|
| 14 |
Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice
|
Dimitriadou, Maria M.
|
|
|
17 |
1 |
p. 235-242
|
artikel
|
| 15 |
Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice
|
Dimitriadou, Maria M.
|
|
|
17 |
1 |
p. 235-242
|
artikel
|
| 16 |
Assessing Cannabis Demand: A Comprehensive Review of the Marijuana Purchase Task
|
Aston, Elizabeth R.
|
|
|
17 |
1 |
p. 87-99
|
artikel
|
| 17 |
Assessing Cannabis Demand: A Comprehensive Review of the Marijuana Purchase Task
|
Aston, Elizabeth R.
|
|
|
17 |
1 |
p. 87-99
|
artikel
|
| 18 |
Assessing Cannabis Demand: A Comprehensive Review of the Marijuana Purchase Task
|
Aston, Elizabeth R.
|
|
|
17 |
1 |
p. 87-99
|
artikel
|
| 19 |
Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
|
Abraham, Amanda J.
|
|
|
17 |
1 |
p. 55-69
|
artikel
|
| 20 |
Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
|
Abraham, Amanda J.
|
|
|
17 |
1 |
p. 55-69
|
artikel
|
| 21 |
Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
|
Abraham, Amanda J.
|
|
|
17 |
1 |
p. 55-69
|
artikel
|
| 22 |
Benzodiazepines, z-Hypnotics, and Risk of Dementia: Special Considerations of Half-Lives and Concomitant Use
|
Tseng, Li-Yen
|
|
|
17 |
1 |
p. 156-164
|
artikel
|
| 23 |
Benzodiazepines, z-Hypnotics, and Risk of Dementia: Special Considerations of Half-Lives and Concomitant Use
|
Tseng, Li-Yen
|
|
|
17 |
1 |
p. 156-164
|
artikel
|
| 24 |
Benzodiazepines, z-Hypnotics, and Risk of Dementia: Special Considerations of Half-Lives and Concomitant Use
|
Tseng, Li-Yen
|
|
|
17 |
1 |
p. 156-164
|
artikel
|
| 25 |
Brain Zinc Deficiency Exacerbates Cognitive Decline in the R6/1 Model of Huntington’s Disease
|
Ayton, Scott
|
|
|
17 |
1 |
p. 243-251
|
artikel
|
| 26 |
Brain Zinc Deficiency Exacerbates Cognitive Decline in the R6/1 Model of Huntington’s Disease
|
Ayton, Scott
|
|
|
17 |
1 |
p. 243-251
|
artikel
|
| 27 |
Brain Zinc Deficiency Exacerbates Cognitive Decline in the R6/1 Model of Huntington's Disease
|
Ayton, Scott
|
|
|
17 |
1 |
p. 243-251
|
artikel
|
| 28 |
Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
|
Pinke, Karen Henriette
|
|
|
17 |
1 |
p. 218-234
|
artikel
|
| 29 |
Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
|
Pinke, Karen Henriette
|
|
|
17 |
1 |
p. 218-234
|
artikel
|
| 30 |
Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
|
Pinke, Karen Henriette
|
|
|
17 |
1 |
p. 218-234
|
artikel
|
| 31 |
Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
|
Mat Nor, Mohd Nasir
|
|
|
17 |
1 |
p. 371-387
|
artikel
|
| 32 |
Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
|
Mat Nor, Mohd Nasir
|
|
|
17 |
1 |
p. 371-387
|
artikel
|
| 33 |
Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
|
Mat Nor, Mohd Nasir
|
|
|
17 |
1 |
p. 371-387
|
artikel
|
| 34 |
Considering Drug-Associated Contexts in Substance Use Disorders and Treatment Development
|
LeCocq, Mandy Rita
|
|
|
17 |
1 |
p. 43-54
|
artikel
|
| 35 |
Considering Drug-Associated Contexts in Substance Use Disorders and Treatment Development
|
LeCocq, Mandy Rita
|
|
|
17 |
1 |
p. 43-54
|
artikel
|
| 36 |
Considering Drug-Associated Contexts in Substance Use Disorders and Treatment Development
|
LeCocq, Mandy Rita
|
|
|
17 |
1 |
p. 43-54
|
artikel
|
| 37 |
Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows
|
Addolorato, Giovanni
|
|
|
17 |
1 |
p. 127-141
|
artikel
|
| 38 |
Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows
|
Addolorato, Giovanni
|
|
|
17 |
1 |
p. 127-141
|
artikel
|
| 39 |
Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows
|
Addolorato, Giovanni
|
|
|
17 |
1 |
p. 127-141
|
artikel
|
| 40 |
Early and Sustained Increases in Leukotriene B4 Levels Are Associated with Poor Clinical Outcome in Ischemic Stroke Patients
|
Chan, Su Jing
|
|
|
17 |
1 |
p. 282-293
|
artikel
|
| 41 |
Early and Sustained Increases in Leukotriene B4 Levels Are Associated with Poor Clinical Outcome in Ischemic Stroke Patients
|
Chan, Su Jing
|
|
|
17 |
1 |
p. 282-293
|
artikel
|
| 42 |
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis
|
Preziosa, Paolo
|
|
|
17 |
1 |
p. 208-217
|
artikel
|
| 43 |
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis
|
Preziosa, Paolo
|
|
|
17 |
1 |
p. 208-217
|
artikel
|
| 44 |
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis
|
Preziosa, Paolo
|
|
|
17 |
1 |
p. 208-217
|
artikel
|
| 45 |
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
|
Clerico, Marinella
|
|
|
17 |
1 |
p. 200-207
|
artikel
|
| 46 |
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
|
Clerico, Marinella
|
|
|
17 |
1 |
p. 200-207
|
artikel
|
| 47 |
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
|
Clerico, Marinella
|
|
|
17 |
1 |
p. 200-207
|
artikel
|
| 48 |
Fabrication and Evaluation of a Xenogeneic Decellularized Nerve-Derived Material: Preclinical Studies of a New Strategy for Nerve Repair
|
Li, Ting
|
|
|
17 |
1 |
p. 356-370
|
artikel
|
| 49 |
Fabrication and Evaluation of a Xenogeneic Decellularized Nerve-Derived Material: Preclinical Studies of a New Strategy for Nerve Repair
|
Li, Ting
|
|
|
17 |
1 |
p. 356-370
|
artikel
|
| 50 |
Fabrication and Evaluation of a Xenogeneic Decellularized Nerve-Derived Material: Preclinical Studies of a New Strategy for Nerve Repair
|
Li, Ting
|
|
|
17 |
1 |
p. 356-370
|
artikel
|
| 51 |
Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
|
Torres, Pascual
|
|
|
17 |
1 |
p. 269-281
|
artikel
|
| 52 |
Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
|
Torres, Pascual
|
|
|
17 |
1 |
p. 269-281
|
artikel
|
| 53 |
Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
|
Torres, Pascual
|
|
|
17 |
1 |
p. 269-281
|
artikel
|
| 54 |
GPCR and Alcohol-Related Behaviors in Genetically Modified Mice
|
Neasta, Jérémie
|
|
|
17 |
1 |
p. 17-42
|
artikel
|
| 55 |
GPCR and Alcohol-Related Behaviors in Genetically Modified Mice
|
Neasta, Jérémie
|
|
|
17 |
1 |
p. 17-42
|
artikel
|
| 56 |
GPCR and Alcohol-Related Behaviors in Genetically Modified Mice
|
Neasta, Jérémie
|
|
|
17 |
1 |
p. 17-42
|
artikel
|
| 57 |
Intranasal Insulin: a Treatment Strategy for Addiction
|
Kashyap, Bhavani
|
|
|
17 |
1 |
p. 105-115
|
artikel
|
| 58 |
Intranasal Insulin: a Treatment Strategy for Addiction
|
Kashyap, Bhavani
|
|
|
17 |
1 |
p. 105-115
|
artikel
|
| 59 |
Intranasal Insulin: a Treatment Strategy for Addiction
|
Kashyap, Bhavani
|
|
|
17 |
1 |
p. 105-115
|
artikel
|
| 60 |
Levo-corydalmine Attenuates Vincristine-Induced Neuropathic Pain in Mice by Upregulating the Nrf2/HO-1/CO Pathway to Inhibit Connexin 43 Expression
|
Zhou, Lin
|
|
|
17 |
1 |
p. 340-355
|
artikel
|
| 61 |
Levo-corydalmine Attenuates Vincristine-Induced Neuropathic Pain in Mice by Upregulating the Nrf2/HO-1/CO Pathway to Inhibit Connexin 43 Expression
|
Zhou, Lin
|
|
|
17 |
1 |
p. 340-355
|
artikel
|
| 62 |
Levo-corydalmine Attenuates Vincristine-Induced Neuropathic Pain in Mice by Upregulating the Nrf2/HO-1/CO Pathway to Inhibit Connexin 43 Expression
|
Zhou, Lin
|
|
|
17 |
1 |
p. 340-355
|
artikel
|
| 63 |
N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug
|
Kamiński, Krzysztof
|
|
|
17 |
1 |
p. 309-328
|
artikel
|
| 64 |
N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug
|
Kamiński, Krzysztof
|
|
|
17 |
1 |
p. 309-328
|
artikel
|
| 65 |
Non-invasive Brain Stimulation for Alcohol Use Disorders: State of the Art and Future Directions
|
Philip, Noah S.
|
|
|
17 |
1 |
p. 116-126
|
artikel
|
| 66 |
Non-invasive Brain Stimulation for Alcohol Use Disorders: State of the Art and Future Directions
|
Philip, Noah S.
|
|
|
17 |
1 |
p. 116-126
|
artikel
|
| 67 |
Non-invasive Brain Stimulation for Alcohol Use Disorders: State of the Art and Future Directions
|
Philip, Noah S.
|
|
|
17 |
1 |
p. 116-126
|
artikel
|
| 68 |
Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations
|
Goodyear, Kimberly
|
|
|
17 |
1 |
p. 100-104
|
artikel
|
| 69 |
Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations
|
Goodyear, Kimberly
|
|
|
17 |
1 |
p. 100-104
|
artikel
|
| 70 |
Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations
|
Goodyear, Kimberly
|
|
|
17 |
1 |
p. 100-104
|
artikel
|
| 71 |
Picrorhiza kurroa Prevents Memory Deficits by Inhibiting NLRP3 Inflammasome Activation and BACE1 Expression in 5xFAD Mice
|
Kim, Namkwon
|
|
|
17 |
1 |
p. 189-199
|
artikel
|
| 72 |
Picrorhiza kurroa Prevents Memory Deficits by Inhibiting NLRP3 Inflammasome Activation and BACE1 Expression in 5xFAD Mice
|
Kim, Namkwon
|
|
|
17 |
1 |
p. 189-199
|
artikel
|
| 73 |
Picrorhiza kurroa Prevents Memory Deficits by Inhibiting NLRP3 Inflammasome Activation and BACE1 Expression in 5xFAD Mice
|
Kim, Namkwon
|
|
|
17 |
1 |
p. 189-199
|
artikel
|
| 74 |
Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder
|
Hamada, Kana
|
|
|
17 |
1 |
p. 4-16
|
artikel
|
| 75 |
Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder
|
Hamada, Kana
|
|
|
17 |
1 |
p. 4-16
|
artikel
|
| 76 |
Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder
|
Hamada, Kana
|
|
|
17 |
1 |
p. 4-16
|
artikel
|
| 77 |
The Long and the Short of Benzodiazepines and Sleep Medications: Short-Term Benefits, Long-Term Harms?
|
DeKosky, Steven T.
|
|
|
17 |
1 |
p. 153-155
|
artikel
|
| 78 |
The Long and the Short of Benzodiazepines and Sleep Medications: Short-Term Benefits, Long-Term Harms?
|
DeKosky, Steven T.
|
|
|
17 |
1 |
p. 153-155
|
artikel
|
| 79 |
The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials
|
Chrzanowski, Stephen M.
|
|
|
17 |
1 |
p. 142-152
|
artikel
|
| 80 |
The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials
|
Chrzanowski, Stephen M.
|
|
|
17 |
1 |
p. 142-152
|
artikel
|
| 81 |
The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials
|
Chrzanowski, Stephen M.
|
|
|
17 |
1 |
p. 142-152
|
artikel
|
| 82 |
Translational Research in the Neurobiological Mechanisms of Alcohol and Substance Use Disorders
|
Haass-Koffler, Carolina L.
|
|
|
17 |
1 |
p. 1-3
|
artikel
|
| 83 |
Translational Research in the Neurobiological Mechanisms of Alcohol and Substance Use Disorders
|
Haass-Koffler, Carolina L.
|
|
|
17 |
1 |
p. 1-3
|
artikel
|
| 84 |
Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia
|
Kútna, Viera
|
|
|
17 |
1 |
p. 329-339
|
artikel
|
| 85 |
Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia
|
Kútna, Viera
|
|
|
17 |
1 |
p. 329-339
|
artikel
|
| 86 |
Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia
|
Kútna, Viera
|
|
|
17 |
1 |
p. 329-339
|
artikel
|
| 87 |
Vildagliptin Attenuates Huntington’s Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
|
Sayed, Noha H.
|
|
|
17 |
1 |
p. 252-268
|
artikel
|
| 88 |
Vildagliptin Attenuates Huntington’s Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
|
Sayed, Noha H.
|
|
|
17 |
1 |
p. 252-268
|
artikel
|
| 89 |
Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
|
Sayed, Noha H.
|
|
|
17 |
1 |
p. 252-268
|
artikel
|
Tijdschrift beschrijving